GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Cash Flow for Lease Financing

Bio-Gate AG (XTER:BIG1) Cash Flow for Lease Financing : €0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG Cash Flow for Lease Financing?

Bio-Gate AG's Cash Flow for Lease Financing for the six months ended in Dec. 2023 was €0.00 Mil. Bio-Gate AG's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Jun. 2023 ), Bio-Gate AG's Cash Flow for Lease Financing remained the same in Dec. 2023 (€0.00 Mil).

Bio-Gate AG Cash Flow for Lease Financing Historical Data

The historical data trend for Bio-Gate AG's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gate AG Cash Flow for Lease Financing Chart

Bio-Gate AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bio-Gate AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bio-Gate AG Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gate AG Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Bio-Gate AG's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Gate AG (XTER:BIG1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XTER:SPM XTER:EDL XTER:BST FRA:DCIK XTER:YOC FRA:IFS XTER:BVB XTER:KA8 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN BAX XPAR:DIM
Traded in Other Exchanges
BIG1:Germany BIG1:Germany
Address
Neumeyerstraße 28-34, Nürnberg, DEU
Website
http://www.biogate.de
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Executives
Karl Richter Supervisory Board

Bio-Gate AG (XTER:BIG1) Headlines

No Headlines